Cargando…
Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome
OBJECTIVE: The purpose of this study was to compare the use of low-dose aspirin alone versus prednisone and low-dose aspirin versus heparin and low-dose aspirin in the treatment of the antiphospholipid antibody syndrome in pregnant women. STUDY DESIGN: A prospective, single-center randomized trial i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661633/ https://www.ncbi.nlm.nih.gov/pubmed/36389195 http://dx.doi.org/10.1016/j.amsu.2022.104807 |
_version_ | 1784830522036322304 |
---|---|
author | Baiazid, Latifa Hraib, Munawar |
author_facet | Baiazid, Latifa Hraib, Munawar |
author_sort | Baiazid, Latifa |
collection | PubMed |
description | OBJECTIVE: The purpose of this study was to compare the use of low-dose aspirin alone versus prednisone and low-dose aspirin versus heparin and low-dose aspirin in the treatment of the antiphospholipid antibody syndrome in pregnant women. STUDY DESIGN: A prospective, single-center randomized trial included 14 patients who were alternately assigned to treatment. Each patient had a history of recurrent miscarriage diagnosed with antiphospholipid syndrome. 5 accepted the treatment of aspirin alone, 5 accepted the combination treatment of aspirin + prednisone, and 4 accepted the combination therapy of aspirin + heparin. Data were compared by the One-way ANOVA test using IBM SPSS stats 19. RESULTS: There were no significant differences in patient outcome data, obstetric complications, and gestational age at delivery in live births between the 3 groups (P > 0.05). However, treatment with aspirin + heparin increased neonatal weight (P < 0.05). CONCLUSIONS: Our data demonstrate the non-superiority one on each other of the three different regimens, except in terms of neonatal weight when aspirin + heparin were used. These findings raise questions about the need for therapies such as heparin and corticosteroids for women with antiphospholipid antibody syndrome, especially in resource-limited settings similar to Syria. |
format | Online Article Text |
id | pubmed-9661633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96616332022-11-15 Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome Baiazid, Latifa Hraib, Munawar Ann Med Surg (Lond) Randomised Trial OBJECTIVE: The purpose of this study was to compare the use of low-dose aspirin alone versus prednisone and low-dose aspirin versus heparin and low-dose aspirin in the treatment of the antiphospholipid antibody syndrome in pregnant women. STUDY DESIGN: A prospective, single-center randomized trial included 14 patients who were alternately assigned to treatment. Each patient had a history of recurrent miscarriage diagnosed with antiphospholipid syndrome. 5 accepted the treatment of aspirin alone, 5 accepted the combination treatment of aspirin + prednisone, and 4 accepted the combination therapy of aspirin + heparin. Data were compared by the One-way ANOVA test using IBM SPSS stats 19. RESULTS: There were no significant differences in patient outcome data, obstetric complications, and gestational age at delivery in live births between the 3 groups (P > 0.05). However, treatment with aspirin + heparin increased neonatal weight (P < 0.05). CONCLUSIONS: Our data demonstrate the non-superiority one on each other of the three different regimens, except in terms of neonatal weight when aspirin + heparin were used. These findings raise questions about the need for therapies such as heparin and corticosteroids for women with antiphospholipid antibody syndrome, especially in resource-limited settings similar to Syria. Elsevier 2022-10-31 /pmc/articles/PMC9661633/ /pubmed/36389195 http://dx.doi.org/10.1016/j.amsu.2022.104807 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Randomised Trial Baiazid, Latifa Hraib, Munawar Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome |
title | Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome |
title_full | Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome |
title_fullStr | Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome |
title_full_unstemmed | Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome |
title_short | Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome |
title_sort | effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome |
topic | Randomised Trial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661633/ https://www.ncbi.nlm.nih.gov/pubmed/36389195 http://dx.doi.org/10.1016/j.amsu.2022.104807 |
work_keys_str_mv | AT baiazidlatifa effectsoflowdoseaspirinandheparinonthepregnancyoutcomeinwomenwithantiphospholipidsyndrome AT hraibmunawar effectsoflowdoseaspirinandheparinonthepregnancyoutcomeinwomenwithantiphospholipidsyndrome |